Target Name: PLCZ1
NCBI ID: G89869
Other Name(s): Testis-development protein NYD-SP27 | phospholipase C zeta 1 | SPGF17 | Phospholipase C zeta 1 | NYD-SP27 | PLC-zeta-1 | PLCZ1_HUMAN | phosphoinositide phospholipase C-zeta-1 | PLCZ1 variant 1 | Testis-development related NYD-SP27 | Phospholipase C zeta 1, transcript variant 1 | PI-phospholipase C zeta 1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 | Phospholipase C-zeta-1 | testis-development related NYD-SP27 | PLCzeta | Phosphoinositide phospholipase C-zeta-1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 (isoform 1) | testicular tissue protein Li 145

PLCZ1: A Potential Drug Target and Biomarker for Testis Development Protein NYD-SP27

Introduction

The development and growth of tissues are critical processes in living organisms, and the testis is a vital organ responsible for the production of sperm and testosterone. Testis development is a complex process, and various factors, including genetics and environmental factors, contribute to its development and function. One of the key proteins involved in testis development is PLCZ1 (Proteolytic Lysine-rich Repeat Zinc Transmembrane 1). PLCZ1 is a zinc-transmembrane protein that plays a crucial role in the development and growth of the testis, and its dysregulation has been associated with a range of reproductive and male-related diseases. In this article, we will explore the biology of PLCZ1 and its potential as a drug target or biomarker.

PLCZ1: Structure and Function

PLCZ1 is a 21-kDa protein that consists of a transmembrane domain and a cytoplasmic tail. The transmembrane domain is characterized by a series of proline-rich repeats, which are involved in the formation of a hydrophobic domain that can interact with various signaling molecules, including Wnt, FGF, and Leptin. The cytoplasmic tail of PLCZ1 consists of a variable region that is involved in the protein's stability and localization to the plasma membrane.

PLCZ1 is involved in the development and growth of the testis, as well as testosterone production. It is highly expressed in the testis, with higher levels observed in the germinal vesicles, which are the early stages of testis development. In addition to its expression in the testis, PLCZ1 is also expressed in various other tissues and organs, including the brain, heart, and pancreas.

PLCZ1 plays a key role in the regulation of cell proliferation and differentiation, as well as in the formation of tissues during development. It is involved in the development of the germinal vesicles, as well as the formation of the testidens, which are the structures that develop into tests. PLCZ1 is also involved in the regulation of the meiotic stage of cell division, which is critical for the formation of reproductive cells.

In addition to its role in testis development, PLCZ1 has also been shown to play a potential role as a drug target or biomarker. Several studies have shown that PLCZ1 can be targeted by small molecules, including inhibitors of the protein's tyrosine kinase activity. These small molecules have been shown to have a range of effects on the behavior of cancer cells, including inhibiting their growth, migration, and invasion.

PLCZ1 has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. PLCZ1 has has been shown to be involved in the regulation of TGF-β signaling in the testis, and its dysregulation has been associated with a range of reproductive and male-related diseases.

PLCZ1 as a Biomarker

PLCZ1 has been shown to be involved in the regulation of various biological processes, including testis development, cell proliferation and differentiation, and cellular signaling pathways. As such, it has potential as a biomarker for a range of reproductive and male-related diseases.

One of the key applications of PLCZ1 as a biomarker is its potential as a diagnostic tool for testis cancer. Testis cancer is a relatively rare type of cancer that is most commonly found in young men. It is often diagnosed at a late stage, and its treatment is often limited to surgical removal of the affected testis, as well as chemotherapy and/or radiation therapy. PLCZ1 has

Protein Name: Phospholipase C Zeta 1

Functions: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. In vitro, hydrolyzes PtdIns(4,5)P2 in a Ca(2+)-dependent manner. Triggers intracellular Ca(2+) oscillations in oocytes solely during M phase and is involved in inducing oocyte activation and initiating embryonic development up to the blastocyst stage. Is therefore a strong candidate for the egg-activating soluble sperm factor that is transferred from the sperm into the egg cytoplasm following gamete membrane fusion. May exert an inhibitory effect on phospholipase-C-coupled processes that depend on calcium ions and protein kinase C, including CFTR trafficking and function

More Common Targets

PLD1 | PLD2 | PLD3 | PLD4 | PLD5 | PLD6 | PLEC | PLEK | PLEK2 | PLEKHA1 | PLEKHA2 | PLEKHA3 | PLEKHA4 | PLEKHA5 | PLEKHA6 | PLEKHA7 | PLEKHA8 | PLEKHA8P1 | PLEKHB1 | PLEKHB2 | PLEKHD1 | PLEKHF1 | PLEKHF2 | PLEKHG1 | PLEKHG2 | PLEKHG3 | PLEKHG4 | PLEKHG4B | PLEKHG5 | PLEKHG6 | PLEKHG7 | PLEKHH1 | PLEKHH2 | PLEKHH3 | PLEKHJ1 | PLEKHM1 | PLEKHM1P1 | PLEKHM2 | PLEKHM3 | PLEKHN1 | PLEKHO1 | PLEKHO2 | PLEKHS1 | PLET1 | Plexin | PLG | PLGLA | PLGLB1 | PLGLB2 | PLGRKT | PLIN1 | PLIN2 | PLIN3 | PLIN4 | PLIN5 | PLK1 | PLK2 | PLK3 | PLK4 | PLK5 | PLLP | PLN | PLOD1 | PLOD2 | PLOD3 | PLP1 | PLP2 | PLPBP | PLPP1 | PLPP2 | PLPP3 | PLPP4 | PLPP5 | PLPP6 | PLPP7 | PLPPR1 | PLPPR2 | PLPPR3 | PLPPR4 | PLPPR5 | PLPPR5-AS1 | PLRG1 | PLS1 | PLS3 | PLSCR1 | PLSCR2 | PLSCR3 | PLSCR4 | PLSCR5 | PLTP | PLUT | PLVAP | PLXDC1 | PLXDC2 | PLXNA1 | PLXNA2 | PLXNA3 | PLXNA4 | PLXNB1 | PLXNB2